AVCO

Avalon GloboCare says its planned acquisition target SenlangBio starts first-in-human clinical trial for recurrent brain cancer

Avalon GloboCare says SenlangBio will enhance its capabilities in cell and gene therapy

Avalon GloboCare CEO Provides Letter to Update Shareholders About Acquisition of SenlangBio

Avalon Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Avalon GloboCare Corp. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – AVCO

Avalon GloboCare Adds Cell Therapy-Based Candidates For Cancer With SenlangBio Acquisition: Highlights

Avalon GloboCare inks definitive agreement to acquire Chinese cell therapy company Senlang Biotechnology

Avalon GloboCare Announces Execution of Purchase Agreement for Acquisition of SenlangBio in All Stock Transaction